16 November 2018; Nottingham, UK: At Drug Delivery to the Lung 2018 (12 – 14th Dec, Edinburgh, UK) Copley Scientific, the global leader in inhaler testing equipment, will release ‘Quality Solutions for Inhaler Testing – 2019 Edition’, the company’s comprehensive brochure that sets products within the context of detailed, practical guidance on all aspects of testing. Substantially updated with new solutions for both novel and generic product development, the brochure is particularly helpful as the regulatory landscape for the industry undergoes significant change. It is a valuable reference resource for anyone working with orally inhaled and nasal drug products (OINDPs) including: metered-dose inhalers (MDIs), dry powder inhalers (DPIs), nebulisers and nasal sprays. Drop by the Copley stand to pick up a copy hot off the press!
Products making their debut in the 2019 Edition reflect a dramatic rise in product-specific Food and Drug Administration (FDA) guidances and US pharmacopoeia monographs. Accessories for testing Albuterol Inhalation Aerosols, for example, answer directly to specifications in the recently proposed draft product-specific US Pharmacopoeia (USP) monograph. New inclusions also support industry efforts towards more clinically representative testing and enhanced reproducibility. The new Facemask Test Stand (FMS) and Next Generation Impactor to FMS Interface Accessory, for instance, make it easier to test nebulisers with a facemask in place to obtain more clinically realistic data. Enhanced IVIVC (in vitro in vivo correlation) test systems all feature.
Several core Copley ancillaries have recently been upgraded to deliver enhanced reproducibility via superior automation, state-of-the-art technology and innovative design. These include the TPK™ 2100 Critical Flow Controller, a vital accessory for DPI testing, and the BAC™ 2100, an advanced Breath Actuation Controller for automating the flow control associated with testing MDIs. Incorporating robust, automated data reporting, these next-generation products make testing easier and more productive, while at the same time minimising the potential impact of user variability.
On display at DDL will be a BAC™ 2100, complete with MDI Actuation Sensor, a discrete device that clips onto the MDI canister to sense manual actuation and enable automatic flow synchronisation. Visit the stand to take a closer look at how it enhances MDI testing, to view other products and/or to find out more about any aspect of inhaler testing.
To see Copley’s full range of equipment for inhaled drug testing download “Quality Solutions for Inhaled Testing” from http://www.copleyscientific.com/downloads/brochures
About Copley Scientific
Copley Scientific is widely recognised as the world’s leading manufacturer and supplier of inhaler test equipment and is a major provider of testing systems for other pharmaceutical dosage forms. The company also supplies equipment for detergent testing.
Copley Scientific’s pharmaceutical product range includes test equipment for all types of orally inhaled and nasal drug products – metered-dose inhalers, dry powder inhalers, nebulizers and nasal sprays – with a particular focus on solutions for delivered dose uniformity and aerodynamic particle size distribution measurement. It also includes testers for tablets (dissolution, disintegration, friability and hardness) capsules, powders, suppositories, semisolids and transdermals.
Used from R&D through to QC, this extensive range of equipment is supported by a full validation and aftersales service. Copley Scientific has offices in the UK and Switzerland and works in partnership with aerosol particle science experts MSP Corporation in North America; specialist distributors extend localised support across the world. This network provides expert help and training to every customer, directly enhancing the application of all Copley Scientific products.